[Asia Economy Reporter Ji Yeon-jin] Myungmoon Pharmaceutical announced on the 12th that it has terminated M2N as the preferred negotiation partner regarding the sale of shares by the largest shareholder.
The company explained, "In the future, if other sale discussions proceed or specific details are confirmed regarding the sale of shares by the largest shareholder, we will disclose them later."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
